• A case presentation of paroxysmal hypnogenic dyskinesia: clinical features and management
• A Novel Missense Variant in the NKX2-1 <em>Homeodomain</em> Prevents Transcriptional Rescue by TAZ
• A Novel Video-Based Methodology for Automated Classification of Dystonia and Choreoathetosis in Dyskinetic Cerebral Palsy During a Lower Extremity Task
• Accidental Falls in Patients with Hyperkinetic Movement Disorders: A Systematic Review
• Acute Onset of Movement Disorders Accompanying Common Emergency Room Neurologic Disease Processes
• Analysis of clinical characteristics and variant of NKX2-1 gene in a Chinese boy with Brain-Lung-Thyroid syndrome
• Atypical Mowat-Wilson Syndrome: Dystonia, Choreoathetosis and Cognitive Features
• Catching the Culprit: How Chorea May Signal an Inborn Error of Metabolism
• Chorea
• Chorea
• Content Validation of the Movement Disorder-Childhood Rating Scale (MD-CRS) for Dyskinetic Cerebral Palsy
• Differences in kinetic characteristics during countermovement jump of football players with cerebral palsy according to impairment profiles
• Dystonic posturing with athetoid movements in stroke without thalamic lesion
• Hemidystonia and hemichorea in a pediatric patient with glucose transporter type 1 deficiency
• Hyperkinesias in Leigh-like Syndrome with Complex-I Deficiency Due to m.10191T&gt;C in MT-ND3
• Idiopathic (Oral) and Tardive Dyskinesia: Pathogenesis, Epidemiology, and Treatment
• Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders
• Juvenile-onset dystonia with spasticity in Leigh syndrome caused by a novel NDUFA10 variant
• Lithium-Induced Awakening of Neural Cell Memory of Involuntary Dyskinesia: A Case Report
• Movement Disorders and Other Neurologic Impairment Associated With Hypomagnesemia: A Systematic Review
• Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies
• Neuropathy with Cerebral Features Induced by Nitrous Oxide Abuse-A Case Report
• Neurosurgical management of non-spastic movement disorders
• Newly identified adverse events for gemcitabine using the Food and Drug Administration Adverse Event Reporting System
• Overview of Movement Disorders Secondary to Drugs
• Para Powerlifting Performance: A Retrospective Analysis Considering Origin of Impairment, Sport Classification, and Sex
• Para Powerlifting performance: A retrospective analysis considering origin of impairment, sport-classification and sex
• Pseudoathetosis: An Unusual Initial Presentation of Compressive Cervical Myelopathy
• Shoulder Movement-Centered Measurement and Estimation Scheme for Underarm-Throwing Motions
• Somatotype Analysis of International Football Players with Cerebral Palsy: A Comparison with Non-Disabled Football Players
• Stakeholders' Consensus to Guide the Minimum Impairment Criteria in Wheelchair Basketball
• The relationship between manual ability, dystonia and choreoathetosis severity and upper limb movement patterns during reaching and grasping in children and young adults with dyskinetic cerebral palsy
• The Study on the Clinical Phenotype and Function of HPRT1 Gene
• Treatment Methods for Dystonia, Myoclonus, and Chorea
• WARS2 Deficiency